Doctor profile · Federal record
Dr. Douglas Rhoda, PAC
Physician Assistant · Millinocket, ME
- NPI 1760494603
- Accepts Medicare
- MIPS 96.8 / 100 · 2023
- 26 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
200 Somerset St
Millinocket, ME 044621258
(207) 723-5161
fax (207) 723-3028 - Mailing address
-
51 North St
Dover Foxcroft, ME 044261141
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Maine #PA-713
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1760494603. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,970
Distinct HCPCS
10
Medicare allowed
$83,132
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 851 | 169 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 455 | 354 | $73 | |
17000 |
Destruction of precancer skin growth, 1 growth | 267 | 212 | $45 | |
11102 |
Biopsy of related skin growth, first growth | 102 | 97 | $76 | |
17110 |
Destruction of skin growth, 1-14 growths | 94 | 84 | $87 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 75 | 75 | $90 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 55 | 47 | $103 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 34 | 33 | $45 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 24 | 23 | $134 | |
11103 |
Biopsy of related skin growth, each additional growth | 13 | 12 | $40 |
In context: peer comparison
Among 2 peers in Millinocket Physician Assistant, average services per provider: 165. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$1,781
Transactions
37
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 10 | $391.72 | |
| Lilly USA, LLC | 3 | $267.52 | |
| Genzyme Corporation | 3 | $209.93 | |
| E.R. Squibb & Sons, L.L.C. | 9 | $203.09 | |
| Sun Pharmaceutical Industries INC. | 3 | $200.81 | |
| Janssen Biotech, INC. | 3 | $176.64 | |
| Amgen INC. | 2 | $103.28 | |
| Regeneron Healthcare Solutions, INC. | 1 | $102.13 | |
| Incyte Corporation | 1 | $91.09 | |
| Pfizer INC. | 1 | $17.23 | |
| Arcutis Biotherapeutics, INC. | 1 | $17.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
923
Patients
519
Total drug cost
$469,031
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 174 | 117 | $1,950 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 132 | 79 | $3,943 |
| Ketoconazole | Generic | 98 | 57 | $3,100 |
| Fluorouracil | Generic | 93 | 90 | $10,185 |
| Fluocinonide | Generic | 86 | 46 | $4,432 |
| Doxycycline Hyclate | Generic | 64 | 44 | $3,154 |
| Otezla (Apremilast) | Brand | 50 | 0 | $252,808 |
| Dupixent Pen (Dupilumab) | Brand | 47 | 0 | $180,055 |
| Mupirocin | Generic | 46 | 36 | $378 |
| Clindamycin Phosphate | Generic | 32 | 13 | $1,649 |
Frequently asked questions
What is Dr. Douglas Rhoda's medical specialty?
Dr. Douglas Rhoda practices Physician Assistant in Millinocket, ME.
Where does Dr. Douglas Rhoda practice?
Dr. Douglas Rhoda practices at 200 Somerset St, Millinocket, ME 044621258. Office phone: 2077235161.
What is Dr. Douglas Rhoda's NPI?
Dr. Douglas Rhoda's National Provider Identifier (NPI) is 1760494603, issued by NPPES.
Does Dr. Douglas Rhoda accept Medicare assignment?
Yes. Dr. Douglas Rhoda accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Douglas Rhoda commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.